Cooperative Agreement UG3DA065139
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $1.7M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Tucson, AZ 85721, USA
Similar Awards
- This Cooperative Agreement award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $3,044,814.00 to the University of California, Irvine to develop a high-speed, multimodal deep tissue imaging system. The key products and services to be delivered under this 2-year award (9/1/2025 - 8/31/2027) include: Developing a reflection matrix-based wavefront shaping system to overcome light scattering limitations and achieve real-time,...
- The National Institutes of Health (NIH) awarded a $1,843,229 Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) to Stanford University, with a project period from September 15, 2025 to August 31, 2027. The project aims to develop a combined Shortwave Infrared (SWIR) Fluorescence and Raman imaging system to enable real-time, high-resolution visualization of tissue structures below the surface. Key objectives include optimizing SWIR Raman imaging to characterize...
- This $462,092 Cooperative Agreement award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) is focused on investigating novel immune checkpoint targets for the topical immunoprevention of keratinocytic skin cancer. The award is held by the University of Arizona and will run from August 1, 2025 to July 31, 2027. The key objectives of the project are to 1) use human samples to identify novel immune checkpoint proteins that are upregulated early in the skin...
- This Cooperative Agreement, awarded by the Department of the Interior's Interior Business Center under the Advanced Research Projects Agency for Health (ARPA-H) federal grant program (CFDA 93.384), provides $4,116,367 to Northeastern University and its sub-awardees University of Washington, Johns Hopkins University, and Massachusetts General Hospital. The funding supports the development of a "Fully Integrated Acousto-Optical Electronic-Photonic System for Real-Time In Vivo 3D Photoacoustic...
- This federal Cooperative Agreement award from the National Institutes of Health (NIH) Trans-NIH Research Support Program (CFDA 93.310) provides $551,250 to the University of California, Los Angeles (UCLA) to develop a novel radiation biodosimeter using autofluorescence imaging. The goal is to determine if radiation-induced autofluorescence can be used as a surrogate for radiation dose and to assess the extent of damage to predict lethality from acute radiation syndrome. The project will...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $623,622 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Arizona to develop a novel Probe-Based Light Sheet Microscopy (PLSM) device for improved screening of anal cancer. The 4-year project aims to evaluate the clinical utility of PLSM for in vivo imaging of the anal mucosa to detect precancerous lesions, as...
- This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $1,116,368 to develop a novel visualization, labeling, and tracking engine for human anatomy to enhance the standardization, precision, and communication of skin cancer data. The project aims to create methods to document reproducible and standardized anatomic site descriptions of skin cancer locations, visualize skin cancer locations, and attach...
- The National Cancer Institute (NCI) awarded a $400,000 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Argosmd, Inc. to develop a low-cost, non-invasive Mini-Reflectance Confocal Microscopy (Mini-RCM) tool for aiding skin cancer diagnosis and treatment. The project aims to address limitations of existing Reflectance Confocal Microscopy (RCM) technology, which is FDA-cleared but has seen limited adoption due to high device cost, lack of portability, and...
- This $923,205 federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable researchers at the University of Rochester and their collaborators to acquire a state-of-the-art Vevo F2 LZR-X ultrasound and photoacoustic imaging system. This advanced small animal imaging instrument will support a wide range of foundational and applied research projects across diverse disciplines at the university, including medicine,...
- This National Science Foundation Project Grant of $495,000 will support the development of biopsy-free, label-free three-dimensional virtual histology of intact skin through March 2025. Funded under the Engineering program (CFDA 47.041), the award to the University of California, Los Angeles aims to advance a machine learning-based technique to transform 3D skin images into virtually stained images that can facilitate accurate and rapid diagnosis of skin lesions without biopsy. Specifically, the...